IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 16 filers reported holding IMMUCELL CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,000 | – | 123 | +112.1% | 0.00% | – |
Q1 2024 | $0 | -100.0% | 58 | -72.1% | 0.00% | – |
Q4 2023 | $1,000 | – | 208 | +670.4% | 0.00% | – |
Q3 2023 | $0 | -100.0% | 27 | -88.8% | 0.00% | – |
Q2 2023 | $1,000 | – | 241 | +173.9% | 0.00% | – |
Q3 2020 | $0 | – | 88 | +8700.0% | 0.00% | – |
Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 1 | -99.8% | 0.00% | – |
Q3 2017 | $3,000 | -25.0% | 501 | +0.2% | 0.00% | – |
Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
Q1 2017 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2016 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | -42.9% | 500 | -50.0% | 0.00% | – |
Q2 2016 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $7,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 101,594 | $523,717 | 0.11% |
Empire Financial Management Company, LLC | 42,000 | $214,620 | 0.09% |
PERRITT CAPITAL MANAGEMENT INC | 29,675 | $151,639 | 0.08% |
Minerva Advisors LLC | 11,958 | $61,105 | 0.04% |
Overbrook Management Corp | 32,857 | $167,899 | 0.04% |
WEALTH EFFECTS LLC | 15,667 | $80,058 | 0.04% |
Prosperity Planning, Inc. | 16,000 | $81,760 | 0.04% |
SHUFRO ROSE & CO LLC | 62,408 | $318,905 | 0.03% |
Strategic Financial Services, Inc. | 31,000 | $159,650 | 0.01% |
Cresset Asset Management, LLC | 100,506 | $517,606 | 0.01% |